Matthew Heeney
Director, Sickle Cell Program · Mass General Brigham
Credentials: · ·
History
- Present
1998–1999- 1995–1998
- 1991–1995
Research
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Nature Genetics · 2008 · 507 citations
The Lancet · 2016 · 384 citations
Diabetes · 2010 · 367 citations
17 papers
12 papers
- SB
10 papers
- CH
8 papers
- JK
8 papers
8 papers
6 papers
5 papers
Clinical trials
- 2017–2022
Dose-Finding Study of SC411 in Children With Sickle Cell Disease
Principal investigator · Unknown · Phase 2
Micelle BioPharma Inc
- 2016–2019
Serum Hepcidin Immunoassay - Laboratory to Marketplace
Principal investigator · Completed
Intrinsic LifeSciences, LLC
- 2005–2008
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
Study chair · Completed
University of Texas Southwestern Medical Center
- 2024–2030
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals